Omar Khan

6.0k total citations · 1 hit paper
87 papers, 3.9k citations indexed

About

Omar Khan is a scholar working on Pathology and Forensic Medicine, Oncology and Neurology. According to data from OpenAlex, Omar Khan has authored 87 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pathology and Forensic Medicine, 25 papers in Oncology and 23 papers in Neurology. Recurrent topics in Omar Khan's work include Multiple Sclerosis Research Studies (37 papers), Peripheral Neuropathies and Disorders (14 papers) and Polyomavirus and related diseases (13 papers). Omar Khan is often cited by papers focused on Multiple Sclerosis Research Studies (37 papers), Peripheral Neuropathies and Disorders (14 papers) and Polyomavirus and related diseases (13 papers). Omar Khan collaborates with scholars based in United States, United Kingdom and Germany. Omar Khan's co-authors include David H. Miller, George P. Rice, Catherine M. Dalton, Paul O’Connor, William Sheremata, Katherine Miszkiel, Lance D. Blumhardt, Michele Libonati, Robert P. Lisak and Alexandros Tselis and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and SHILAP Revista de lepidopterología.

In The Last Decade

Omar Khan

84 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

2003 936 citations Omar Khan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Omar Khan United States	33	2.1k	950	917	715	599	87	3.9k
Walter Hader Canada	36	2.2k 1.0×	502 0.5×	1.3k 1.4×	823 1.2×	699 1.2×	101	5.4k
Jeremy Chataway United Kingdom	39	2.6k 1.3×	524 0.6×	1.1k 1.2×	767 1.1×	762 1.3×	171	5.1k
John R. Corboy United States	32	2.3k 1.1×	527 0.6×	1.1k 1.2×	730 1.0×	628 1.0×	110	3.9k
Stephen Lake United States	28	2.1k 1.0×	790 0.8×	772 0.8×	964 1.3×	705 1.2×	66	5.6k
Óscar Fernández Spain	35	3.1k 1.5×	956 1.0×	1.2k 1.3×	1.1k 1.6×	960 1.6×	199	4.9k
Johann Sellner Germany	32	1.6k 0.7×	432 0.5×	1.4k 1.5×	620 0.9×	366 0.6×	172	3.8k
David Laplaud France	37	2.0k 0.9×	591 0.6×	986 1.1×	1.3k 1.9×	449 0.7×	117	4.1k
Giulio Disanto United Kingdom	35	3.4k 1.6×	767 0.8×	1.3k 1.4×	808 1.1×	556 0.9×	93	5.4k
Tobias Ruck Germany	34	1.1k 0.5×	538 0.6×	1000 1.1×	819 1.1×	340 0.6×	184	4.0k
Oluf Andersen Sweden	39	2.6k 1.2×	782 0.8×	1.5k 1.6×	860 1.2×	912 1.5×	135	5.9k

Countries citing papers authored by Omar Khan

Since Specialization

Citations

This map shows the geographic impact of Omar Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omar Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omar Khan more than expected).

Fields of papers citing papers by Omar Khan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omar Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omar Khan. The network helps show where Omar Khan may publish in the future.

Co-authorship network of co-authors of Omar Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Omar Khan. A scholar is included among the top collaborators of Omar Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omar Khan. Omar Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Khan, Omar, et al.. (2021). Clinical Predictors of Mortality in Patients with Moderate to Severe Mitral Regurgitation. The American Journal of Medicine. 135(3). 380–385.e3. 9 indexed citations

Khan, Omar, Miriam Elman, Scott Chadderdon, et al.. (2019). Clinical and Echocardiographic Predictors of Outcomes in Patients With Moderate (Mean Transvalvular Gradient 20 to 40 mm Hg) Aortic Stenosis. The American Journal of Cardiology. 124(12). 1924–1931. 10 indexed citations

Murdock, Richard C., et al.. (2017). Hybridization State Detection of DNA-Functionalized Gold Nanoparticles Using Hyperspectral Imaging. International Journal of Optics. 2017. 1–12. 2 indexed citations

Kaushik, Deepak, Heather Yong, Jennifer Hahn, et al.. (2016). Evaluating Soluble EMMPRIN as a Marker of Disease Activity in Multiple Sclerosis: Studies of Serum and Cerebrospinal Fluid. PLoS ONE. 11(10). e0163802–e0163802. 5 indexed citations

Zivadinov, Robert, Michael G. Dwyer, Niels Bergsland, et al.. (2015). MRI indicators of brain tissue loss: 3-year results of the Glatiramer Acetate Low-frequency Administration (GALA) open-label extension study in relapsing-remitting multiple sclerosis (P7.255). Neurology. 84(14_supplement). 1 indexed citations

Bradley, Kailyn, et al.. (2015). The role of the kynurenine pathway in suicidality in adolescent major depressive disorder. Psychiatry Research. 227(2-3). 206–212. 90 indexed citations

Bernitsas, Evanthia, Fen Bao, Navid Seraji‐Bozorgzad, et al.. (2014). Spinal cord atrophy in multiple sclerosis and relationship with disability across clinical phenotypes. Multiple Sclerosis and Related Disorders. 4(1). 47–51. 33 indexed citations

Zivadinov, Robert, et al.. (2014). Effect of glatiramer acetate three-times weekly on the evolution of new, active multiple sclerosis lesions into T1-hypointense “black holes”: a post hoc magnetic resonance imaging analysis. Journal of Neurology. 262(3). 648–653. 19 indexed citations

Khan, Omar, et al.. (2013). The impact of the specialist colorectal surgeons in management of emergency right colon cancer. International Journal of Surgery. 11(8). 701–701. 1 indexed citations

10.

Stüve, Olaf, Bernd C. Kieseier, Bernhard Hemmer, et al.. (2010). Translational Research in Neurology and Neuroscience 2010. Archives of Neurology. 67(11). 1307–15. 13 indexed citations

11.

Menge, Til, Martin S. Weber, Bernhard Hemmer, et al.. (2008). Disease-Modifying Agents for Multiple Sclerosis. Drugs. 68(17). 2445–2468. 49 indexed citations

12.

Boster, Aaron, Gilles Edan, Adil Javed, et al.. (2008). Intense immunosuppression in patients with rapidly worsening multiple sclerosis: treatment guidelines for the clinician. The Lancet Neurology. 7(2). 173–183. 57 indexed citations

13.

Khan, Omar, et al.. (2007). Lung Cancer Masquerading as Prosthetic Valve Endocarditis. Heart Lung and Circulation. 17(2). 161–163. 4 indexed citations

14.

Khan, Omar & Mark R. Middleton. (2007). The therapeutic potential ofO⁶-alkylguanine DNA alkyltransferase inhibitors. Expert Opinion on Investigational Drugs. 16(10). 1573–1584. 36 indexed citations

15.

Ryan, Kelly A., et al.. (2006). Predictors of Subjective Well-being among Individuals with Multiple Sclerosis. The Clinical Neuropsychologist. 21(2). 239–262. 48 indexed citations

16.

Khan, Omar, Geoffrey Tsang, Clifford W. Barlow, & Khalid Amer. (2006). Routine Histological Analysis of Resected Lung Tissue in Primary Spontaneous Pneumothorax—Is It Justified?. Heart Lung and Circulation. 15(2). 137–138. 7 indexed citations

17.

Khan, Omar, Christopher Torrens, David E. Noakes, et al.. (2005). Effects of pre-natal and early post-natal undernutrition on adult internal thoracic artery function. European Journal of Cardio-Thoracic Surgery. 28(6). 811–815. 11 indexed citations

18.

Field, Mark, et al.. (2005). Functional compartmentation of glycogen phosphorylase with creatine kinase and Ca2+ATPase in skeletal muscle. Journal of Theoretical Biology. 238(2). 257–268. 14 indexed citations

19.

Lim, Eric, Tom Routledge, Stephen J. Kirtland, et al.. (2004). Clopidogrel did not inhibit platelet function early after coronary bypass surgery: A prospective randomized trial. Journal of Thoracic and Cardiovascular Surgery. 128(3). 432–435. 19 indexed citations

20.

Khan, Omar, Qian Xia, C. T. Bever, et al.. (1996). Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration. Neurology. 46(6). 1639–1643. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact